Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metastatic medullary thyroid cancer presenting with elevated levels of CA 19-9 and CA 125.

Thyroid : official journal of the American Thyroid Association - 1 Aug 2011

Milman Sofiya, Whitney Kathleen D, Fleischer Norman

Abstract excerpt

BACKGROUND: Calcitonin and carcinoembryonic antigen (CEA) are established markers of medullary thyroid cancer (MTC), used in the diagnosis and monitoring of disease and its progression. In clinical practice, various other tumor markers are utilized in the follow-up of different malignancies, alth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to CA-125 Antigen
Share to CA-19-9 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Neuroendocrine

Share to Multiple Endocrine Neoplasia Type 2b

Share to Neoplasm Metastasis

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 21751886
DOI: 10.1089/thy.2010.0425

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21751886-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Metastatic medullary thyroid cancer presenting with elevated levels of CA 19-9 and CA 125.PMID 21751886Read ↗

Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.Semantic proximity Read ↗

Circulating Biomarkers in Medullary Thyroid Carcinoma: Assays, Clinical Performance, and Integrated AlgorithmsSemantic proximity Read ↗

Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?Semantic proximity Read ↗

Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.Semantic proximity Read ↗

Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.Semantic proximity Read ↗

T Cells Engineered to Express Immunoreceptors Targeting the Frequently Expressed Medullary Thyroid Cancer Antigens Calcitonin, CEA, and RET M918T.Semantic proximity Read ↗

[Successful selpercatinib treatment of metastatic medullary thyroid cancer carrying rare RET variant].Semantic proximity Read ↗

Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.Semantic proximity Read ↗

Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its PrecursorsSemantic proximity Read ↗

Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma.Semantic proximity Read ↗

Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.